China Stroke Primary Prevention Trial 2 for Participants With Hypertension and MTHFR 677 TT Genotype

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 24000 participants.

Also called NCT04974151

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 24,000 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT04974151
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT04974151. Randomized; quadruple masking; primary purpose treatment. Start 2024-08-22 (actual); primary completion 2029-06-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
China Stroke Primary Prevention Trial 2 for Participants With Hypertension and MTHFR 677 TT Genotype
Acronym
CSPPT2-TT
Condition
Hypertension
Condition
MTHFR 677 TT Genotype
Intervention (Drug)
Amlodipine besylate
Intervention (Drug)
Amlodipine besylate And Folic Acid
Intervention (Drug)
5-methyltetrahydrofolate (5-MTHF)
Intervention (Drug)
Amlodipine placebo
Intervention (Drug)
Amlodipine folic acid placebo
Intervention (Drug)
5-MTHF Placebos
Lead sponsor
Shenzhen Ausa Pharmed Co.,Ltd (class: industry)
Collaborator
Peking University First Hospital (class: other)
Collaborator
Second Affiliated Hospital of Nanchang University (class: other)
Collaborator
The First People's Hospital of Lianyungang (class: other)
Collaborator
The Affiliated Hospital Of Guizhou Medical University (class: other)
Collaborator
Lianyungang Oriental Hospital (class: other)
Collaborator
Tengzhou Central People's Hospital (class: other government)
Collaborator
The First Affiliated Hospital of Bengbu Medical University (class: other)
Collaborator
Shenzhen Prospective Medical Technology Co., LTD (class: not stated)
Collaborator
Weinan Central Hospital (class: other)
Collaborator
The First Affiliated Hospital of Hunan University of Traditional Chinese Medicine (class: other)
Collaborator
Loudi Central Hospital (class: other)
Collaborator
Yancheng First People's Hospital (class: other)
Collaborator
TAIHE country people's hospital (class: not stated)
Collaborator
First Affiliated Hospital of Gannan Medical University (class: other)
Collaborator
Yangjiang People's Hospital (class: other)
Collaborator
Deyang People's Hospital (class: other)
Collaborator
Bozhou people's hospital (class: not stated)
Collaborator
Chizhou people's hospital (class: not stated)
Collaborator
Lianyungang Second People's Hospital (class: not stated)
Collaborator
The Affiliated Hospital Of Southwest Medical University (class: other)
Collaborator
Chengdu Fifth People's Hospital (class: other)

Registry records

Assembled by a program from ROR and ClinicalTrials.gov. No person wrote or checked these pages, and they are counted apart from the pages that people wrote. Lists of trials come from the registry's own coding and may miss trials.

Registry organizations 13

Record details

Record id
cardio:ct-nct04974151
Content hash
04036adb69572b2ca1d36469dd07f06758fbf2e9e61006f6ddccc40427755d63